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OBJECTIVE — Prehypertension is associated with cardiovascular disease and insulin resis-
tance. However, whether subjects with prehypertension have more diabetes risk is not known.
We examine whether prehypertension is a risk factor for developing type 2 diabetes.
RESEARCH DESIGN AND METHODS — Incident diabetes was examined in nondia-
betic normotensive participants in the San Antonio Heart Study (n  2,767; aged 25–65 years;
median follow-up 7.8 years).
RESULTS — Incident diabetes was 12.4% in subjects with prehypertension and 5.6% in
subjects with normal blood pressure. The odds of incident diabetes were 2.21 greater for
individualswithprehypertensionthanforthosewithnormalbloodpressure(95%CI1.63–2.98)
after adjusting for age, sex, and ethnicity. Prehypertension was not associated with incident
diabetes after additional adjustment for BMI, impaired glucose tolerance, insulin resistance and
secretion, and family history of diabetes (odds ratio 1.42 [95% CI 0.99–2.02]).
CONCLUSIONS — Subjectswithprehypertensionareatincreasedriskofdiabetes.Muchof
this risk is explained by disorders related to the insulin resistance syndrome.
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H
ypertension predicts future cardio-
vascular disease (1,2) and type 2 dia-
betes (3). Prehypertension (systolic
blood pressure [SBP] 120–139 mmHg
and/or diastolic blood pressure [DBP]
80–89 mmHg), a novel blood pressure
category of “The Seventh Report of the
Joint National Committee on Preven-
tion, Detection, Evaluation, and Treat-
ment of High Blood Pressure: the JNC 7
report” (4), is also associated with in-
creasedcardiovascularrisk(5,6)andin-
sulin resistance (7). Furthermore,
results from the Framingham Heart
Study indicate that cardiovascular risk
may be more relevant in individuals
with SBP 130–139 mmHg and/or DBP
85–89 mmHg (8). Therefore, we inves-
tigated the relationship between prehy-
pertension and incident type 2 diabetes
in the San Antonio Heart Study (SAHS).
RESEARCH DESIGN AND
METHODS— The SAHS is a longitu-
dinalepidemiologicalstudyoncardiovas-
cular disease and type 2 diabetes in
Mexican Americans and non-Hispanic
whites living in San Antonio, Texas (aged
25–65 years). Details of the study design,
including blood pressure measurement
protocols and laboratory details, have
been published previously (9,10). Sub-
jects were seen only at the initial encoun-
ter and at follow-up.
We used JNC 7 criteria to deﬁne nor-
malbloodpressure,prehypertension,and
hypertension (4). Diabetes was deﬁned as
fasting plasma glucose 126 mg/dl, 2-h
plasma glucose 200 mg/dl, and/or use
ofglucose-loweringagents;impairedfast-
ing glucose (IFG) as fasting glucose
100–25 mg/dl; and impaired glucose tol-
erance (IGT) as 2-h plasma glucose 140–
199 mg/dl (11). The homeostasis model
assessment of insulin resistance (HOMA-
IR)and-cellfunction(HOMA-C)were
used to quantify the level of insulin resis-
tance and secretion (12).
After excluding individuals with
baseline hypertension or diabetes (n 
1,171)orindividualswhodidnotpresent
forthefollow-upexam(n1,220),there
were 2,767 (69.4%) subjects eligible for
analysis. Median follow-up time was 7.8
years (range 6.3–10.7 years).
The relationship between baseline
characteristics and prehypertension was
examined using one-way ANCOVA for
continuous variables and logistic regres-
sion analysis for dichotomous variables.
The relation of measures of blood pres-
sure to metabolic variables was assessed
by Pearson’s partial correlation coefﬁ-
cients. Multivariate logistic regression
analysis was used to examine the risk
of future diabetes associated with pre-
hypertension.
RESULTS— The prevalence of prehy-
pertension at baseline was 31.3%. Prehy-
pertension was associated with male sex
and Mexican-American ethnic origin as
well as with higher BMI, HOMA-IR,
HOMA-C, and levels of fasting glucose,
2-h glucose, fasting insulin, and triglycer-
ides(P0.001forallcomparisons)(sup-
plemental Table, available in an online
appendix at http://care.diabetesjournals.
org/cgi/content/full/dc09-0328/DC1).
After adjusting for age, sex, and eth-
nicity, SBP was positively related to BMI
(r  0.32), waist circumference (r 
0.29), HOMA-IR (r  0.17), HOMA-C
(r  0.11), as well as levels of 2-h glucose
(r  0.14), fasting insulin (r  0.17), and
triglycerides (r  0.18) (all correlations,
P  0.001).
There were 213 (7.7%) new cases of
diabetes: 12.4% (10.4–14.9) in subjects
with prehypertension and 5.6% (4.7–
6.8) in those with normal blood pressure.
After adjusting for age, sex, and ethnicity,
the odds of incident diabetes were 2.21
greater for individuals with prehyperten-
sion than for individuals with normal
bloodpressure(95%CI1.63–2.98).After
the additional adjustment for BMI, IGT,
HOMA-IR, HOMA-C, and family his-
tory of diabetes, diabetes risk associated
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signiﬁcant (odds ratio 1.42 [95% CI
0.99–2.02]; P  0.052). The risk re-
mained signiﬁcant for SBP 130–139
mmHg and/or DBP 85–89 mmHg (1.69
[1.03–2.77]) but did not remain signiﬁ-
cant for SBP 120–129 mmHg and DBP
80–84 mmHg (1.31 [0.88–1.94]).
Subjects with prehypertension had
morediabetesriskthanthosewithnormal
blood pressure regardless of sex, ethnic
origin, and categories of obesity and glu-
cose tolerance (Fig. 1). Prehypertension
was also associated with increased diabe-
tes risk in individuals aged 25–49 years
but not in those aged 50–65 years (n 
752; P  0.127).
CONCLUSIONS — Our study con-
ﬁrms previous reports on the relation of
prehypertensiontoobesity(13)andinsu-
lin resistance (7) and demonstrates that
individuals with prehypertension have
higher rates of conversion to diabetes
than those with normal blood pressure.
Much of the diabetes risk associated with
prehypertension is explained by disor-
ders related to the insulin resistance
syndrome.
Subjects with prehypertension have
morediabetesriskthanthosewithnormal
blood pressure regardless of sex, ethnic-
ity, and categories of obesity and glucose
tolerance. However, prehypertension is
not associated with incident diabetes in
subjects aged 50 years. Potential expla-
nations may be a lack of statistical power
(n752)oralesserrelationshipbetween
blood pressure and insulin resistance in
individuals aged 50 years.
Asigniﬁcantlimitationinourstudyis
the lack of information on waist circum-
ference, chronic inﬂammation, and phys-
ical activity for all participants. These
confounders could be relevant for ex-
plaining the relationship between prehy-
pertension and incident diabetes.
Insummary,ourstudyshowsthatsub-
jects with prehypertension had greater risk
of converting to diabetes than those with
normal blood pressure. Further study is
needed regarding mechanisms of this phe-
nomenon and treatment options for partic-
ipants with prehypertension.
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